Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Paoletti

Showing results (61-70 of 145) with videos related to

Pageof 15
Sort By:
Clinical and Translational Radiation Oncology|March 24, 2025
From pre-clinical studies to human treatment with proton-minibeam radiation therapy: adapted Idea, Development, Exploration, Assessment and Long-term evaluation (IDEAL) framework for innovation in radiotherapyEmmanuel Jouglar, Ludovic de Marzi, Pierre Verrelle, et al.
Contemporary Clinical Trials|April 18, 2021
Impact of follow-up on generalized pairwise comparisons for estimating the irinotecan benefit in advanced/metastatic gastric cancerAli N Chamseddine, Koji Oba, Marc Buyse, et al.
International Journal of Radiation Biology|July 16, 2021
Acute and late toxicities of patients infected with SARS-CoV-2 and treated for cancer with radiation therapy during the COVID-19 pandemicArnaud Beddok, Marion Chevrier, Valentin Calugaru, et al.
European Journal of Cancer (Oxford, England : 1990)|April 13, 2011
Heterogeneity in the definition of dose-limiting toxicity in phase I cancer clinical trials of molecularly targeted agents: a review of the literatureChristophe Le Tourneau, Albiruni R A Razak, Hui K Gan, et al.
Chinese Clinical Oncology|April 6, 2015
The spectrum of clinical trials aiming at personalizing medicineChristophe Le Tourneau, Maud Kamal, Marie Alt, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 11, 2023
Survival after sentinel lymph node biopsy for early cervical cancers: a systematic review and meta-analysisGiulia Parpinel, Enora Laas-Faron, Vincent Balaya, et al.
European Heart Journal|April 20, 2012
Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program)Sylvain Beurtheret, Pierre Mordant, Xavier Paoletti, et al.
Plos One|February 28, 2019
Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non-muscle-invasive bladder cancer and with low and intermediate EORTC-risk scoreMarie Simon, Pierre-Olivier Bosset, Mathieu Rouanne, et al.
Journal of Hepatology|November 27, 2012
The added value of quality of life (QoL) for prognosis of overall survival in patients with palliative hepatocellular carcinomaMomar Diouf, Thomas Filleron, Jean-Claude Barbare, et al.
Frontiers in Oncology|August 29, 2022
Estimation risk of lymph nodal invasion in patients with early-stage cervical cancer: Cervical cancer applicationBenedetta Guani, Thomas Gaillard, Ly-Ann Teo-Fortin, et al.
Pageof 15

Showing results (61-70 of 145) with videos related to

Sort By:
Pageof 15
Clinical and Translational Radiation Oncology|March 24, 2025
From pre-clinical studies to human treatment with proton-minibeam radiation therapy: adapted Idea, Development, Exploration, Assessment and Long-term evaluation (IDEAL) framework for innovation in radiotherapyEmmanuel Jouglar, Ludovic de Marzi, Pierre Verrelle, et al.
Contemporary Clinical Trials|April 18, 2021
Impact of follow-up on generalized pairwise comparisons for estimating the irinotecan benefit in advanced/metastatic gastric cancerAli N Chamseddine, Koji Oba, Marc Buyse, et al.
International Journal of Radiation Biology|July 16, 2021
Acute and late toxicities of patients infected with SARS-CoV-2 and treated for cancer with radiation therapy during the COVID-19 pandemicArnaud Beddok, Marion Chevrier, Valentin Calugaru, et al.
European Journal of Cancer (Oxford, England : 1990)|April 13, 2011
Heterogeneity in the definition of dose-limiting toxicity in phase I cancer clinical trials of molecularly targeted agents: a review of the literatureChristophe Le Tourneau, Albiruni R A Razak, Hui K Gan, et al.
Chinese Clinical Oncology|April 6, 2015
The spectrum of clinical trials aiming at personalizing medicineChristophe Le Tourneau, Maud Kamal, Marie Alt, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 11, 2023
Survival after sentinel lymph node biopsy for early cervical cancers: a systematic review and meta-analysisGiulia Parpinel, Enora Laas-Faron, Vincent Balaya, et al.
European Heart Journal|April 20, 2012
Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program)Sylvain Beurtheret, Pierre Mordant, Xavier Paoletti, et al.
Plos One|February 28, 2019
Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non-muscle-invasive bladder cancer and with low and intermediate EORTC-risk scoreMarie Simon, Pierre-Olivier Bosset, Mathieu Rouanne, et al.
Journal of Hepatology|November 27, 2012
The added value of quality of life (QoL) for prognosis of overall survival in patients with palliative hepatocellular carcinomaMomar Diouf, Thomas Filleron, Jean-Claude Barbare, et al.
Frontiers in Oncology|August 29, 2022
Estimation risk of lymph nodal invasion in patients with early-stage cervical cancer: Cervical cancer applicationBenedetta Guani, Thomas Gaillard, Ly-Ann Teo-Fortin, et al.
Pageof 15